REPLICATION COMPETENT RETROVIRUS TESTING (RCR) IN THE NATIONAL GENE VECTOR BIOREPOSITORY: NO EVIDENCE OF RCR IN 1595 POST-TREATMENT PERIPHERAL BLOOD SAMPLES OBTAINED FROM 60 CLINICAL TRIALS

By sjmartinez • December 16, 2022

Cornetta K, Yao J, House K, Duffy L, Adusumilli PS, Beyer R, Booth C, Brenner M, Curran K, Grilley B, Heslop H, Hinrichs CS, Kaplan RN, Kiem HP, Kochenderfer J, Kohn DB, Mailankody S, Norberg SM, O'Cearbhaill RE, Pappas J, Park J, Ramos C, Ribas A, Rivièra I, Rosenberg SA, Sauter C, Shah N, Slovin SF, Thrasher A, Williams DA, Lin TY. REPLICATION COMPETENT RETROVIRUS TESTING (RCR) IN THE NATIONAL GENE VECTOR BIOREPOSITORY: NO EVIDENCE OF RCR IN 1595 POST-TREATMENT PERIPHERAL BLOOD SAMPLES OBTAINED FROM 60 CLINICAL TRIALS. Mol Ther. 2022 Dec 13:S1525-0016(22)00710-9. doi: 10.1016/j.ymthe.2022.12.006. Epub ahead of print. PMID: 36518078.

Tags: Hematology/Oncology, Publications

Characteristics of clinical trials associated with appeal and return on investment to participants, A Review and Framework

Fernandez Turizo MJ, Velez MA, Glenn B, Cummings AL, Segarra-Vazquez B, Gorbatov S, Park SJ, Shen C, Lind-Lebuffe JP, Unger JM, Garon EB. Characteristics of[...]

IGF2BP3 redirects glycolytic flux to promote one-carbon metabolism and RNA methylation

Sharma G, Gutierrez M, Jones AE, Kapoor S, Jaiswal AK, Neeb ZT, Rios A, Dorairaj P, Thaxton ML, Lin TL, Tran TM, Kabbani LES, Ritter[...]

Ribociclib Plus Endocrine Therapy in Hormone Receptor-Positive/ERBB2-Negative Early Breast Cancer: 4-Year Outcomes From the NATALEE Randomized Clinical Trial

Fasching PA, Stroyakovskiy D, Yardley DA, Huang CS, Crown J, Bardia A, Chia S, Im SA, Martin M, Xu B, Loi S, Barrios C, Untch[...]